Since October 2011, USAMMDA’s PSPMO has managed the supply of two types of adenovirus vaccine for administration to service members during basic training. Production of the tablets, which have been highly effective in reducing febrile respiratory illness in the U.S. military population, is possible only through an industry partner- ship with a commercial manufacturing company. (Photo courtesy of USAMMDA Public Affairs)